[TORONTO, July 17, 2023] — BioPharma Services, a leading Clinical Research Organization (CRO) globally renowned for advancing healthcare through clinical studies, recently completed a comprehensive inspection conducted by the World Health Organization (WHO) and Health...

Following the recent inspection of the clinical site in St. Louis, Missouri (and previous to that, the Toronto clinic site in May 2022), FDA Inspectors came on site to inspect the BioPharma Services’ bioanalytical laboratory in Toronto, Canada. During the week of...

BioPharma Services is pleased to share that our US clinical site located near St. Louis, Missouri was the subject of an unannounced FDA inspection from October 4-6, 2022. Though BioPharma has a long successful FDA regulatory history in the US at the previous Columbia,...

BioPharma Services Inc. is happy to report the successful completion of another regulatory industry audit. During the week of September 12, 2022, BioPharma was host to a multi-agency inspection.  Leading the inspection were inspectors from the Austrian Agency for...

Revenue recognition commencing in September to October timeframe. Average length of each program is approximately 12 months. TORONTO, ON, March 29, 2022 – Think Research Corporation (TSXV:THNK) (“Think” or the “Company”), a healthcare technology company focused on...

TORONTO, ON - June 16, 2022 - Think Research Corporation (TSXV:THNK) (OTCQB: THKKF) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, is pleased to announce its subsidiary, BioPharma Services Inc.,...